92
Participants
Start Date
May 11, 2022
Primary Completion Date
October 25, 2023
Study Completion Date
November 13, 2023
Telitacicept
subcutaneous injection
standard therapy
A standard regimen consists of the following medication(s) (alone or in combination)：corticosteroids, anti-malarials, non-steroidal anti-inflammatory drugs (NSAIDs), other immunosuppressive or immunomodulatory agents including azathioprine, mycophenolate mofetil, cyclophosphamide, methotrexate, leflunomide, tacrolimus, cyclosporine.
Peking Union Medical College Hospital, Beijing
The First Hospital of China Medical University, Shenyang
The First Affiliated Hospital of University of Science and Technology of China, Hefei
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Qilu Hospital of Shandong University, Jinan
Yantai Yuhuangding Hospital, Yantai
General Hospital of Tianjin Medical University, Tianjin
The Second Affiliated Hospital of Zhejiang University, Hangzhou
Xiangya Hospital, Central South University, Changsha
The Second Xiangya Hospital of Central South University, Changsha
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
Affiliated Hospital of Guilin Medical University, Guilin
The First People's Hospital of Yunnan Province, Kunming
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
The People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi
Affiliated Hospital of Hebei University, Baoding
The Second Hospital of Hebei Medical University, Shijiazhuang
The Second Hospital of Shanxi Medical University, Taiyuan
Shanxi Bethune Hospital, Taiyuan
RemeGen Co., Ltd.
INDUSTRY